Cargando…
BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
BACKGROUND: The evasion from apoptosis is a common strategy adopted by most tumors, and inhibitors of apoptosis proteins (IAPs) are among the most studied molecular and therapeutic targets. BIRC3 (cellular IAP2) and BIRC5 (survivin) are two of the eight members of the human IAPs family. This family...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792207/ https://www.ncbi.nlm.nih.gov/pubmed/33413657 http://dx.doi.org/10.1186/s13578-020-00521-0 |